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The ability of chelated Gd to serve as an effective magnetic resonance (MR) contrast agent largely depends on fast
exchangeratesbetweentheGd-boundwatermoleculesandthesurroundingbulkwater.Becausewaterdiffusesslowly
across lipid bilayers, liposomes with encapsulated chelated Gd have not been widely adopted as MR contrast agents.
To overcome this limitation, we have synthesized chemically stabilized, porous polymersomes with encapsulated
gadolinium (Gd) chelates. The polymerosmes, 125 nm in diameter, were produced from the aqueous assembly of
diblockcopolymers,PEO(1300)-b-PBD(2500)(PBdEO),andphospholipids,1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phocholine (POPC). The PBdEO was cross-linked using a chemical initiator and the POPC was extracted with
surfactant, generating a highly porous outer membrane. The encapsulated Gd chelates were attached to dendrimers
to prevent their leakage through the pores. It was estimated that, on average, nearly 44 000 Gd were encapsulated
withineachpolymersome.AsaresultoftheslowerrotationalcorrelationtimeofGd-labeleddendrimersandtheporous
outer membrane, the paramagnetic porous polymersomes exhibited an R1 relaxivity of 7.2 mM-1 s1- per Gd and
315 637 mM-1 s-1 per vesicle. This corresponds to a relaxivity that is ampliﬁed by a factor of ∼105 compared with
Gd-DTPA.
Introduction
Magnetic resonance (MR) imaging procedures have become
acommonpracticeindiagnosticclinicalmedicineowingtotheir
ability to provide high-resolution three-dimensional images of
softtissue.Manyofthesediagnosticproceduresutilizeintravenous
MR contrast agents, such as gadolinium (Gd), to improve tissue
contrast and to provide important information about perfusion,
vascular permeability, and extracellular volume.
1–3 The recent
development of targeted paramagnetic contrast agents promises
to even further expand the utility of diagnostic MR imaging by
providingamechanismtoprobethemolecularproﬁleoftissues.
Inordertocompensateforthelowsignalenhancementgenerated
by individual Gd ions, most targeted Gd compounds have relied
onthedevelopmentofnanoplatformsthatcancarryahighpayload
of chelated Gd and which exhibit high longitudinal relaxivities
(R1).Ingeneral,theR1ofGd-basedcontrastagentsisdependent
ontwokeyfeatures,thewater-exchangeratebetweenbulkwater
andwaterboundtothechelatedGdandtherotationalcorrelation
time of the Gd ions.
4The rotational correlation lifetime is
generally increased through conjugation of Gd chelates to
macromolecular objects. A wide range of macromolecules
and other nanoparticulate systems have already been tested
as platforms for Gd labeling. Some examples include
dendrimers,
5,6 polymers,
7 liposomes,
8–12 micelles,
13,14 emul-
sions,
15 and silica
16–18 nanoparticles. For these multimeric
gadolinium complexes, it is not only the relaxivity per Gd that
deﬁnestheeffectivenessofthecontrastagentbutalsothenumber
of chelated Gd per nanoparticle. These two parameters can be
represented as the relaxivity per nanoparticle.
Among the many nanoparticulate systems, those that are self-
assembledfromamphiphilicmolecules(i.e.,liposomes,micelles,
and emulsions) are particularly attractive due to their unique
structure wherein the hydrophobic domain serves as a natural
carrierenvironmentforhydrophobicdrugsandtheexteriorsurface
providesaplatformforattachingtargetingligands.Amphiphilic
nanoparticles are easily transformed into paramagnetic contrast
agents by either encapsulating chelated Gd within the hollow
core (in the case of liposomes) or through the immobilization
of chelated Gd onto the outer membrane surface. Although,
liposomes with encapsulated Gd-chelates have previously been
used for contrast-enhanced MR imaging, the slow ﬂux of water
across the membrane bilayer does impair the water exchange
ratewithencapsulatedGdandthusleadstoasigniﬁcantreduction
inrelaxivity.
8Whilethiscanbepartiallyovercomebyincreasing
thesurface-to-volumeratio(i.e.,decreasingthesizeofthevesicle),
even liposomes 100 nm in diameter have been shown to exhibit
arelaxivity(perGd)thatis62%lowerthanfreechelatedGd.
8,12
Reagents that are commonly used to increase the stability of
liposomes,suchascholesterol.evenfurtherreducetherelaxivity
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9 Because of these concerns, vesicles with
encapsulated Gd chelates have been all but abandoned as MR
contrast agents and liposomes, micelles, and perﬂuorocarbon
emulsions with Gd immobilized on the surface have become the
preferred embodiment for MR imaging applications.
10,13–15 In
this study, we revive the possibility of using Gd-encapsulated
vesicles with the development of a new porous polymersome
nanoplatform, in which Gd relaxivity is not compromised
following encapsulation but, in fact, improved. By taking
advantage of the large intraparticle volume, we also show that
muchlargerpayloadsofGdperparticlecanbeachievedcompared
withvesiclesofsimilarsizecontainingsurface-immobilizedGd.
Porous polymersomes are composed of three key features: (1)
a stabilized polymer shell, (2) a porous membrane structure that
allows for improved water ﬂux across the bilayer, and (3) a
dendrimer-attached Gd complex that is loaded inside the porous
vesicles for MRI detection.
Experimental Section
Materials. PEO(1300)-b-PBD(2500) (PBdEO) was purchased
from Polymer Source (Dorval, Quebec, Canada). 1-Palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) and 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N-(lissaminerhodamineBsulfonyl)
(Rhod-PE)wereobtainedfromAvantiPolarLipids(Alabaster,AL).
PAMAM dendrimers (ethylenediamine core, generation 2) were
fromAldrichChemicalCo.as20%w/vsolutionsinmethanol.5-(and-
6)-Carboxyﬂuorescein (CF) and tetramethylrhodamine-5-(and-6)-
isothiocyanate (TRITC) were obtained from Molecular Probes.
Diethylenetriaminepentaaceticaciddianhydride(DTPAdianhydride),
gadolinium(III)chloride,potassiumpersulfate,sodiummetabisulﬁte,
andiron(II)sulfateheptahydratewereobtainedfromSigma-Aldrich.
Allotherchemicalwereusedasreceived.Allofthebuffersolutions
were prepared with DI water.
Synthesis of PAMAM-DTPA-Gd. A 126 mg portion of
PAMAM was dissolved with 5 mL of sodium bicarbonate buffer
(0.1M,pH9.5)andreactedwith400mgofDTPAdianhydride.The
reaction solutions were maintained at pH 9.5 with NaOH over the
reaction time of 10 h. The PAMAM-DTPA was puriﬁed by
centrifugal ﬁlter devices (Amicon Ultra-4, 5000 MWCO, Millipore
Corp.). The puriﬁed PAMAM-DTPA conjugates were mixed with
100 mg of GdCl3 in 0.1 M citrate buffer (pH 5.6) for overnight at
42°C.TheunreactedGd3+wasremovedbycentrifugalﬁlterdevices
(Amicon Ultra-4, 5000 MWCO, Millipore Corp.) while simulta-
neouslychangingthebufferto0.1MPBSbuffer.Toensurecomplete
removalofunreactedGd3+,theGdcontentintheeluentwaschecked
after each centrifugation by performing a Xylenol Orange assay
untilnoGd3+wasdetectable.
19ThepuriﬁedPAMAM-DTPA-Gd
conjugates were used for vesicle encapsulation.
Preparation of Giant Vesicles. Giant vesicles were prepared as
previously described.
20,21 Brieﬂy, appropriate amounts of PBdEO,
POPC, and Rhod-PE at a molar ratio of 85:14:1 were dissolved in
chloroform. The solvent was then removed using a direct stream of
nitrogen prior to vacuum desiccation for a minimum of 4 h. The
giant vesicles were formed upon the addition of 285 mOsm sucrose
solutiontodriedﬁlmandincubatedinthe65°Cwaterbathformore
than 24 h.
Preparation of Nanometer-Sized Vesicles. Nanometer-sized
vesicleswerepreparedusingtheﬁlmhydrationtechnique.Anaqueous
solution (0.1 M PBS, pH 7.0) was added to dried PBdEO ﬁlm with
15% POPC or without POPC and incubated in a 65 °C water bath
for 0.5 h and then sonicated for another1ha tt h esame temperature.
Samples were subjected to 10 freeze-thaw-vortex cycles in liquid
nitrogen and warm H2O (65 °C), followed by extrusion 21 times
through two stacked 100 nm Nuclepore polycarbonate ﬁlters using
a stainless steel extruder (Avanti Polar Lipids).
For dye encapsulation, 1 mL of 100 mM CF or 0.5 mL of
PAMAM-TRITC(40mg/mLPAMAM)in0.1Msodiumphosphate
(pH 7.0) was added to the dried PBdEO/POPC (mole ratio 85/15,
10 mg of PBdEO) ﬁlms and freeze-thaw and extrusion were
performed as described. Nonentrapped CF and PAMAM-TRITC
were removed via size exclusion chromatography using Sepharose
CL-4B (Sigma-Aldrich) and rehydration buffer as the eluent.
For PAMAM-DTPA-Gd encapsulation, 1 mL of PAMAM-
DTPA-GdwasaddedtothedriedPBdEO/POPC(moleratio85/15,
100 mg of PBdEO). Nonentrapped PAMAM-DTPA-Gd was
removed through repeated washing on centrifugal ﬁlter devices
(Amicon Ultra-4, 100K MWCO, Millipore Corp.). To ensure
completeremovalofPAMAM-DTPA-Gd,theT1relaxationtime
of the eluent was checked after each centrifugation until no Gd was
detectable, i.e. until the T1 relaxation time was equivalent to that
of sodium phosphate (pH 7.0) buffer (∼1000 ms). T1 relaxation
times were determined using a Bruker mq60 MR relaxometer
operating at 1.41 T (60 MHz).
PolymersomePolymerization.Polybutadieneinthecoresofthe
vesicle membranes was cross-linked by free radical polymerization
in solution.
22–25 Speciﬁcally, 100 mg of potassium persulfate was
added into polymersome solution and then stirred for 1 h. The
polymerization was initiated by injecting appropriate amounts of
redox couple, Na2S2O5/FeSO4·7H2O, in the sequence of sodium
metabisulﬁte and ferrous sulfate. All cross-linking polymerizations
were performed at ﬁxed weight ratios of 1:1:0.5:0.02 between the
PBdEO, potassium persulfate, sodium metabisulﬁte, and ferrous
sulfate.
POPCExtraction.ToremovePOPCfrompolymerizedvesicles,
Triton X-100 was added into polymerized vesicles and incubated
for 10 min with shaking. The ﬁnal concentration of Triton X-100
is10mM.TritonX-100wassubsequentlyremovedthroughrepeated
washingoncentrifugalﬁlterdevices(AmiconUltra-4,100KMWCO,
Millipore Corp.)
Quantiﬁcation of Gd Encapsulation. To determine the number
ofGdperporouspolymersome,itwasassumedthatnoneofthe100
mg of polymer was lost during the synthesis process. The number
of polymersomes in the puriﬁed sample was then calculated by
determining the amount of polymer in each vesicle. For this
calculation, the average diameter of each polymersome was taken
to be 125 nm. Further, the average area occupied by single polymer
molecules in a bilayer has previously been determined to be ∼1
nm2.
22 The average area occupied by single POPC molecules in a
bilayer has previously been determined to be ∼0.65nm2,
26 and the
thicknessofthepolymersomebilayerhaspreviouslybeendetermined
to be ∼10 nm.
27 The amount of Gd in the polymersome sample was
measured by ICP-AES.
Instrumentation.Dynamiclightscattering(DLS)measurements
were performed on a Zetasizer Nano from Malvern Instruments.
The scattering angle was held constant at 90°. Microscopy
measurements were performed on an Olympus IX 81 motorized
inverted ﬂuorescence microscope equipped with an Andor DU897
EMCCD, an X-Cite 120 excitation source (EXFO), and Sutter
excitation and emission ﬁlter wheels. The image of Rhod-PE was
acquired using the ﬁlter sets HQ560/55, HQ645/75, and Q595LP
(Chroma). The exposure time was 100 ms. Fluorescence spectra
measurementsweredoneonaSPEXFluoroMax-3spectroﬂuorometer
(19) Kamaly, N.; Kalber, T.; Ahmad, A.; Oliver, M. H.; So, P. W.; Herlihy,
A.H.;Bell,J.D.;Jorgensen,M.R.;Miller,A.D.BioconjugateChem2008,19(1),
118–29.
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Sci. U.S.A. 2005, 102(8), 2922–7.
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15388–90.
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Bruker mq60 MR relaxometer operating at 1.41 T (60 MHz). ICP-
AES was performed by VHG Laboratories (Manchester, NH).
Results and Discussion
An overview of the approach used to synthesize chemically
stabilized, porous polymersomes is depicted in Figure 1.
Preparation of the porous polymersomes required generation-2
dendrimers to ﬁrst be labeled with Gd-DTPA. The Gd-labeled
dendrimerswerethenencapsulatedintovesiclesassembledfrom
a mixture of polymerizable amphiphillic diblock copolymer
[PEO(1300)-b-PBD(2500),PBdEO]andnonpolymerizabenative
phospholipid (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line, POPC). To conﬁrm that nonpolymerizable phospholipids
wereintegratedintothepolymerbilayerduringvesicleformation,
a low molar percentage of ﬂuorescent phospholipid was used
during fabrication. A classical swelling technique was also
adopted to form giant vesicles that could be observed by
microscopy.
20,21 As shown in Figure 2, incorporation of the
ﬂuorescentlipidintothepolymersomebilayerwasevidentatthe
resolution of the optical microscope. This result demonstrates
the feasibility of forming polymer-lipid hybrid vesicles.
Followingtheformationofvesicles,theaveragehydrodynamic
diameterwasreducedto∼125nm((2.5nmstandarddeviation)
by subjecting the sample to multiple freeze-thaw cycles and
extrusion through a 100 nm polybicarbonate ﬁlter. The hydro-
dynamic diameter was measured by dynamic light scattering.
Though vesicles were extruded through 100 nm pores, the
resultingvesiclesarelargerthanthecorrespondingporediameter.
This difference may result from the interplay between the
mechanical constraints of the extrusion and the energetic
constraints of the vesicles. It should be noted that the polymer
vesicle does possess a relatively thick hydrophobic domain (∼8
nm).
28
Once the extrusion process was complete, the diblock
copolymers were cross-linked via free radical polymerization,
and the stability of the polymerized vesicles was examined by
surfactant solubilization.
22–25 Speciﬁcally, polymerized and
unpolymerizedvesiclesweretreatedwithTritonX-100atahigh
molar ratio of Triton X-100-to-polymer. Treatment of unpoly-
merized vesicles with Triton X-100 led to complete vesicle
dissolution (data not shown), as determined by dynamical light
scattering(DLS).Thevesiclesdissolveandformmixedmicelles
when the surfactant concentration exceeds its critical concentra-
tion. When the chemically cross-linked polymersomes were
treated with a high concentration of Triton X-100, the mean
vesicle diameter was essentially unchanged compared with
vesicles that had not been treated with Triton X-100 (Figure 3).
The second peak centered at 10 nm can be attributed to Triton
X-100 micelles in the same solution. A similar peak at 10 nm
wasobservedinsamplescontainingjustTritonX-100.Theability
to impart structural stability into vesicle bilayer architectures is
likely to prove highly beneﬁcial in biological applications that
requirenanoplatformswithlonginvivohalf-lives.
29Thediversity
of applications in which many phospholipid-based vesicles can
(28) Discher, B. M.; Won, Y. Y.; Ege, D. S.; Lee, J. C.; Bates, F. S.; Discher,
D. E.; Hammer, D. A. Science 1999, 284(5417), 1143–6.
(29) LeDuc, P. R.; Wong, M. S.; Ferreira, P. M.; Groff, R. E.; Haslinger, K.;
Koonce, M. P.; Lee, W. Y.; Love, J. C.; McCammon, J. A.; Monteiro-Riviere,
N.A.;Rotello,V.M.;Rubloff,G.W.;Westervelt,R.;Yoda,M.Nat.Nanotechnol.
2007, 2(1), 3–7.
Figure 1. Schematic diagram illustrating the approach used to synthesize paramagnetic porous polymersomes. (a) Vesicles consisting of the diblock
copolymer PBdEO and the phospholipid POPC at a molar ratio of 85:15 were prepared. Second-generation dendrimer conjugated Gd chelates were
encapsulated within the aqueous interior during vesicle formation. (b) Cross-linking of PBdEO within the vesicle bilayer was induced by free radical
polymerization. (c) Pores were formed in the polymersome bilayer by extracting the POPC with the surfactant Triton X-100.
Figure 2. Microscopy images of giant vesicles composed of diblock
copolymers and lipids. The vesicles were ﬂuorescently labeled by
incorporatingthephospholipidrhodamine-PEintothemembranebilayer:
(a) phase contrast image and (b) ﬂuorescence image. Fluorescence is
seen in individual giant vesicles. The scale bar represents 25 µm.
Figure 3. Intensity-weighted hydrodynamic diameter measurements of
cross-linkedpolymersomesbeforeandafteraddingthesurfactantTriton
X-100 (ﬁnal concentration ) 8.3 mM). The measuring angle of DLS
is 90°. When the chemically cross-linked polymersomes were treated
withTritonX-100,themeanvesiclediameter(∼125nm)wasunchanged
comparedwithvesiclesthathadnotbeentreatedwithTritonX-100.The
second peak that arises at 10 nm can be attributed to Triton X-100
micelles in the same solution.
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30
These ﬁndings suggest that polymerized polymersomes may
provide a stable, alternative platform to liposomes.
Following polymerization of the diblock copolymers, the
nonpolymerizable phospholipids were removed by extraction
with Triton X-100, leaving pores within the membrane bilayer.
A visible loss of the rhodamine-labeled phospholipid was
observed, while dynamic light scattering conﬁrmed that the
polymersomes retained their structure (Figure 3). To conﬁrm
that pores were, in fact, created, chemically stabilized porous
polymersomessimilartothosedescribedaboveweresynthesized
withcarboxyﬂuoresceinencapsulatedwithinthecore.Following
the extraction of the phospholipids with Triton X-100, the
polymersomes were centrifuged on a Microcon centrifugal
ﬁltering device (Millipore) with a molecular weight cutoff of
100kDa.Theliquidthatﬂowedthroughtheﬁlterwasthentested
for ﬂuorescence. It was hypothesized that if pores were present
inthepolymersome,theencapsulatedcarboxyﬂuoresceinwould
diffuse across the membrane bilayer and pass through the ﬁlter
duringcentrifugation.Alternatively,ifnoporeswerepresent,no
ﬂuorescence would be detected in the ﬂow-through because the
carboxyﬂuorescein would remain entrapped within the poly-
mersomes,whicharetoolargetopassthroughtheﬁlter.Asseen
in Figure 4A, when polymerized polymersomes were treated
withTritonX-100,4timesmorecarboxyﬂuoresceinwasdetected
in the ﬂow-through compared with vesicles that had not been
treated with Triton X-100. Samples that were not treated with
Triton X-100 likely exhibit a weak ﬂuorescent signal due to a
small amount of free carboxyﬂuorescein that was not removed
duringpolymersomepuriﬁcation.Whenanalogousstudieswere
performed on polymersomes that had not been doped with
phospholipids (i.e., no pores), only 1.2 times more carboxy-
ﬂuorescein ﬂuorescences was detected in the ﬂow-through
following treatment with Triton X-100 (Figure 4B). This small
increaseisduetotheeffectofTritonX-100oncarboxyﬂuorescein
ﬂuorescence.Theseresultsclearlydemonstratethathighlyporous
vesiclescanbecreatedthoughthesurfactant-mediatedextraction
of lipids from polymerized hybrid vesicles.
Although diffusion of water across the polymersome bilayer
isdesirable,theleakageofGd-labeleddendrimerfromthevesicle
would be detrimental to the utility of the probe. To conﬁrm that
second-generationdendrimersweretoolargetopassthroughthe
porous membrane of the polymerized vesicles, TRITC-labeled
dendrimers were encapsulated within the core of the chemically
stabilized porous polymersomes. Following centrifugation on
the Microcon ﬁltering device, no ﬂuorescence was detected
in the ﬂow-through, suggesting that the dendrimer is retained
within the porous vesicle (Figure 5). A similar assay was also
conductedwithpolymersomescontainingGd-labeleddendrimers,
where T1 measurements of the ﬂow-through were conducted to
conﬁrm the absence of Gd. As expected, the T1 relaxation time
of the ﬂow-through was similar to that of pure phosphate buffer,
∼1000 ms. Assuming, that between 50 and 100% of the amines
on each PAMAM dendrimer were labeled with DTPA-Gd, the
estimatedmolecularweightofPAMAM-DTPA-Gdisbetween
7500 and 12 000 Da.
To assess the loading efﬁciency and paramagnetic properties
of the chemically stabalized porous polymersomes, the amount
of Gd in the polymersome sample was determined by ICP-AES.
The relaxivity of the Gd within the polymersomes was then
calculated as the slope of the curves 1/T1 vs Gd concentration,
asshowninFigure6.T1relaxationtimesweredeterminedusing
a Bruker mq60 MR relaxometer operating at 1.41 T (60 MHz)
and at 40 °C. It was found that the R1 relaxivity per Gd was 7.2
mM-1 s-1. Polymersomes with encapsulated Gd-labeled den-
drimer but no pores exhibited an R1 relaxivity of 3.1 mM-1 s-1
per Gd. Assuming no polymer was lost during the synthesis
processandanaveragepolymersomediameterof125nm,itwas (30) Kirby, C.; Clarke, J.; Gregoriadis, G. Biochem. J. 1980, 186(2), 591–8.
Figure 4. Evaluation of pore formation within cross-linked polymersomes following surfactant solubilization. The water-soluble, low-molecular-
weight dye carboxyﬂuorescein was encapsulated into chemically cross-linked polymersomes with and without 15% phospholipid. The polymerized
vesicles were treated with an equivalent volume of buffer or Triton X-100 (ﬁnal concentration ) 10 mM) and then centrifuged on a Microcon
centrifugal ﬁltering device with a 100 kDa MWCO membrane (Millipore). The liquid that ﬂowed through the ﬁlter was tested for ﬂuorescence. (a)
Cross-linked polymersomes doped with 15% phospholipid. (b) Cross-linked polymersomes without phospholipids.
Figure5.Retentionofgeneration-2dendrimerwithincross-linkedporous
polymersomes. TRITC-labeled dendrimer was encapsulated into chemi-
cally cross-linked polymersomes containing 15% phospholipid. The
polymerized vesicles were treated with an equivalent volume of buffer
or Triton X-100 (ﬁnal concentration ) 10 mM) and then centrifuged
on a Microcon centrifugal ﬁltering device with a 100 kDa MWCO
membrane (Millipore). The liquid that ﬂowed through the ﬁlter was
tested for ﬂuorescence. The emission spectrum of vesicles treated with
Triton X-100 was nearly identical to that of the vesicles treated by
buffer,indicatingthatthedendrimerisretainedwithintheporousvesicles.
8172 Langmuir, Vol. 24, No. 15, 2008 Cheng and Tsourkasestimated that there were approximately 43 838 Gd per porous
polymersome. The relaxivity per porous polymersome was then
calculated, giving an R1 equal to 315 637 mM-1s-1. For
comparison,chelatedGdalonewasdeterminedtopossessanR1
relaxivityof3.9mM-1s-1.Therefore,thepolymersomesgenerate
arelaxivitythatisampliﬁedbyafactorof∼105forT1-weighted
imaging.
The paramagnetic properties of the polymersomes reported
here compare very favorably with Gd-based agents that have
previously been reported in the literature. For example, Gd-
labeledshell-cross-linkednanoparticles(40nmdiameter)exhibit
an R1 of 39 mM-1 s-1 per Gd (0.47 T) but possess only 510 Gd
per particle, which results in an R1 of 2 × 104 mM-1 s-1 per
nanoparticle.
14 This relaxivity is signiﬁcantly lower than the
paramagnetic porous polymersomes presented here.
Paramagneticsilicananoparticles(∼100nm)havebeenfound
to exhibit an R1 of 9.0 mM-1 s-1 per Gd (4.7 T) and contain
16 000 Gd per nanoparticle, which results in an R1 of 1.4 × 105
mM-1 s-1 per nanoparticle.
18 While these properties are similar
to those of the paramagnetic polymersomes, polymersomes
possess a hydrophobic domain that presents a natural carrier
environmentforhydrophobicdrugs.Thismayallowparamagnetic
porous polymersomes to be more readily adapted for combined
targeted drug delivery and MR imaging.
PerﬂuorocarbonnanoparticleshaveareportedR1of25.3mM-1
s-1 per Gd (1.5 T) and 94 200 Gd per particle, which results in
an R1 of 2.38 × 106 mM-1 s-1 per nanoparticle. Although this
relaxivityishigherthanthatofthe125nmpolymersomesreported
here, it should be noted that the perﬂuorocarbon particles are
much larger with a diameter of 273 nm.
15 Scaling with volume,
a porous polymersome of this size would possess 456 681 Gd
and exhibit an R1 of 3.3 × 106 mM-1 s-1 per polymersome.
Also, while perﬂuorocarbons only exhibit a half-life of ∼1h ,
polymersomes ∼100 nm in diameter have a reported plasma
half-life of >15 h.
27,31 The smaller size and extended half-life
of polymersomes could provide important advantages in mo-
lecular imaging applications, including improved tissue penetra-
tion and increased target site accumulation.
32
Conclusion
In conclusion, the preparation of chemically stabilized
porous polymersomes for magnetic resonance imaging ap-
plications has been described. The porous vesicle membrane
leads to a signiﬁcant improvement in the water-exchange rate
of the encapsulated Gd due to the faster ﬂux of water across
thebilayer.Therelaxivityofthenanoparticleisalsoimproved
due to the slower rotational correlation lifetime of the
encapsulatedGd-dendrimers.Inaddition,thepolymersomes
possess an unobstructed outer surface that may be used for
attaching targeting ligands and a hydrophobic domain that
presentsanaturalcarrierenvironmentforhydrophobicdrugs.
Therefore, the porous polymersomes described here provide
a powerful new platform for combined targeted drug delivery
and MR imaging.
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Figure 6. Relaxivity determination for Gd-dendrimer conjugates
encapsulated within cross-linked porous polymersomes. Comparisons
aremadetoGd-dendrimerconjugatesencapsulatedwithincross-linked
polymersomesthatdonotcontainporesandtoGd-DTPA.Measurements
were acquired at 1.41 T (60 MHz) at 40 °C.
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